Intraarterial Thrombolysis for Treatment of Acute Stroke:Experience in 26 Patients with Long-Term Follow-Up
AJNR 20:1291-1299, 1194, Jahan,R.,et al, 1999
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 48:2031-2033, Tsivgoulis, G. & Safouris, A., 2017
Preexisting Cerebral Microbleeds on Susceptibility-Weighted Magnetic Resonance Imaging and Post-Thrombolysis Bleeding Risk in 392 Patients
Stroke 45:1684-1688, Gratz, P.P.,et al, 2014
Thrombolysis of Basilar Artery Occlusion: Impact of Baseline Ischemia and Time
Ann Neurol 73:688-694, Strbian, D.,et al, 2013
Subtherapeutic Warfarin Is Not Associated With Increased Hemorrhage Rates in Ischemic Strokes Treated With Tissue Plasminogen Activator
Stroke 42:1041-1045, Vergouwen,M.D.I.,et al, 2011
Intravenous thrombolysis in acute ischaemic stroke: a systematic review and meta-analysis to aid decision making in patients over 80 years of age
JNNP 82:712-717, Bhatnagar, P.,et al, 2011
Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis
Stroke 42:2333-2335, Seet, R.C.S.,et al, 2011
Safety of Intravenous Thrombolysis for Acute Ischemic Stroke in Patients Receiving Antiplatelet Therapy at Stroke Onset
Stroke 41:288-294, Diedler,J.,et al, 2010
Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Arch Neurol 67:559-563, Prabhakaran,S., et al, 2010
Management of Thrombolysis-Associated Symptomatic Intracerebral Hemorrhage
Arch Neurol 67:965-969, Goldstein,J.N., et al, 2010
Predictors of Subarachnoid Hemorrhage in Acute Ischemic Stroke With Endovascular Therapy
Stroke 41:2775-2781, Shi,Z.-S.,et al, 2010
Safety of Antiplatelet Therapy Prior to Intravenous Thrombolysis in Acute Ischemic Stroke
Arch Neurol 65:607-611,575, Uyttenboogaart,M.,et al, 2008
Symptomatic Intracerebral Hemorrhage and Recanalization After IV rt-PA: A Multicenter Study
Neurol 71:1304-1312, Saqqur,M.,et al, 2008
Ischemic and Hemorrhagic Complications After Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion
AJNR 28:378-381, Schulte-Altedorneburg,G.,et al, 2007
Hemorrhage After Thrombolytic Therapy for Stroke: The Clinically Relevant Number Needed to Harm
Stroke 38:2279-2283, Saver,J.L., 2007
Prediction of Hemorrhagic Transformation After Recanalization Therapy Using T2*-Permeability Magnetic Resonance Imaging
Ann Neurol 62:170-176, Bang,O.Y.,et al, 2007
Hypoattenuation on CT Angiographic Source Images Predicts Risk of Intracerebral Hemorrhage and Outcome After Intra-Arterial Reperfusion Therapy
AJNR 26:1798-1803, Schwamm,L.,et al, 2005
Magnetic Resonance Imaging Improves Detection of Intracerebral Hemorrhage Over Computed Tomography after Intra-Arterial Thrombolysis
Stroke 35:491-495, Greer,D.M.,et al, 2004
Multiple Cerebral Microbleeds:MRI Marker of a Diffuse Hemorrhage-Prone State
J Neuroimaging 14:54-57, Chalela,J.A.,et al, 2004
Predictors of Hemorrhagic Transformation in Patients Receiving Intra-Arterial Thrombolysis
Stroke 33:717-724, Kidwell,C.S.,et al, 2002
Thrombolysis-Related Hemorrhagic Infarction
Stroke 33:1551-1556,1446, Molina,C.A.,et al, 2002
Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke
Stroke 33:2866-2870, Lisboa,R.C.,et al, 2002
Risk Factors for Sever Hemorrhagic Transformation in Ischemic Stroke Patients Treated with Recombinant Tissue Plasminogen Activator
Stroke 32:438-441, Larrue,V.,et al, 2001
Safety of Intra-Arterial Thrombolysis in the Postoperative Period
Stroke 32:1365-1369, Chalela,J.A.,et al, 2001
Parenchymal Hyperdensity on Computed tomography after Intra-Arterial Reperfusion Therapy for Acugte Middle Cerebral Artery Occlusion,Incidence and Clinical Significance
Stroke 32:2042-2048, Nakano,S.,et al, 2001
Cerebral Hemorrhage After Intra-arterial Thrombolysis for Ischemic Stroke
Neurol 57:1603-1610, Kase,C.S.,et al, 2001
Intravenous Tissue-Type Plasminogen Activator Therapy for Ischemic Stroke
Arch Neurol 58:2009-2013, Grotta,J.C.,et al, 2001
Intravenous Tissue-Type Plasminogen Activator for Treatment of Acute Stroke
JAMA 283:1145-1150,1189, Albers,G.W.,et al, 2000
Use of Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
JAMA 283:1151-1158,1189, Katzan,I.L.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Cerebral Venous Thrombosis,Combined Intrathrombus rtPA and Intravenous Heparin
Stroke 30:489-494,481, Frey,J.L.,et al, 1999
Initial Clinical Experience with IV Tissue Plasminogen Activator for Acute Ischemic Stroke:A Multicenter Survey
Neurol 53:424-427, Tanne,D.,et al, 1999
Predictors of Clinical Improvement,Angiographic Recanalization, and Intracranial Hemorrhage After Intra-Arterial Thrombolysis for Acute Ischemic Stroke
Stroke 30:2094-2100, Suarez,J.I.,et al, 1999
Intra-Arterial Prourokinase for Acute Ischemic Stroke, The PROACT II Study:A Randomized Controlled Trial
JAMA 282:2003-2011, Furlan,A.,et al, 1999
Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, The ATLANTIS Study:A Randomized Controlled Trial
JAMA 282:2019-2026, Clark,W.M.,et al, 1999
PROACT:Recombinant Pro-Urokinase by Direct Arterial Delivery in Acute MCA Stroke
Stroke 29:4-11, delZoppo,G.J.,et al, 1998
I. V. t-PA for Acute Ischemic Stroke, Feasibility, Safety & Efficacy in the First Year of Clinical Practice
Stroke 29:18-22, Chiu,D.,et al, 1998
Randomised Double-Blind Placebo-Controlled Trial of Thrombolytic Therapy with Intravenous Alteplase in Acute Ischaemic Stroke (ECASS II)
Lancet 352:1245-1251,1238, Hacke,W.,et al, 1998
Brain SPECT with HMPAO & Safety of Thrombolytic Therapy in Acute Ischemic Stroke
Stroke 28:1830-1834, Alexandrov,A.V.,et al, 1997
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group, Stroke 28:2109-21181997., , 1997
Acute Stroke:Usefulness of Early CT Findings Before Thrombolytic Therapy
Radiology 205:327-333, von Kummer,R.,et al, 1997
Intraarterial Thrombolysis in Vertebrobasilar Occlusion
AJNR 17:255-262, Becker,K.J.,et al, 1996
Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
The MAST-E Study Group, NEJM 335:145-1501996., , 1996
Clin Features & Pathog of Intracerebral Hemorrhage after rt-PA & Heparin Therapy for Acute Myocardial Infarct
Neurol 45:649-658, Sloan,M.A.,et al, 1995
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Acute Hemispheric Stroke:The ECASS
JAMA 274:1017-1025, 10581995., Hacke,W.,et al, 1995
Tissue Plasminogen Activator for Acute Ischemic Stroke
National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, NEJM 333:1581-1587, 12,1995., 1995
Randomised Contr Trial of Streptokinase
Aspirin & Comb in Trtm of Acute Ischaemic Stroke, Multictr Acute Stroke Trial-Italy, Lancet 346:1509, 15145,1504,1995., 1995
Evaluation of Risk of Hemorrhagic Transformation in Local Intra-arterial Thrombolysis in Acute Ischemic Stroke by Initial SPECT
Stroke 25:298-303, Ueda,T.,et al, 1994
Hirudin in Acute Myocardial Infarction
Circulation 90:1624-1630, 1631, 2147994., Antman,E.M., 1994